Devices to Fight Obesity to Launch in 2011
Three new fat removal technologies that are awaiting approval from the US Food and Drug Administration should be available to patients by 2011.
Three new fat removal technologies that are awaiting approval from the US Food and Drug Administration should be available to patients by 2011.
Armenia has announced a programme that will pump more than $8.6m into the healthcare sector to improve the quality and accessibility of healthcare for children.
Health Sciences Online has launched a website where anyone can access more than 50,000 courses, references, guidelines, and other expert-reviewed, high-quality, current, cost-free, and ad-free health sciences resources.
Researchers have recently discovered that a protein Nrf2 plays a vital role in some antioxidant therapies and also promotes atherosclerosis – clogging of arteries.
A research from UC Davis Cancer Center has revealed that a person screening for colon cancer often depends on where they live in addition to their race or ethnicity.
A study says that over-the-counter painkillers, used for treating inflammation, can increase the risk of heart attacks and strokes.
Medtronic has announced funding of $750,000 to support healthcare infrastructure development in Haiti.
New Delhi is going to host 63rd Annual National Conference of the Indian Psychiatric Society (ANCIPS) at Ashoka Hotel, Chanakya Puri, from 16th to 19th January.
Scientists at the University of Bristol, Swansea University and the Bristol Haematology and Oncology Centre are developing a device to reduce the risk of radiotherapy mistreatment.
A new study has found that most anti-epileptic drugs are linked with an increased risk of non-traumatic fracture in older adults 50 years of age and older.
The researchers from University of Georgia have developed a technique to diagnose a common type of pneumonia within minutes.
A report by Research and Markets says that the global market for endoscopy devices is estimated to exceed $6.5bn by 2016.
Scientists at Inserm and Institut Pasteur has developed a prognostic test that can predict the efficacy of hepatitis C treatments has been developed. The commercialisation of the test is expected in 2011.